Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Z Best Place to Talk Stocks -- Ignore unavailable to you. Want to Upgrade?

To: chowder who wrote (52391)	11/7/2004 12:24:44 PM
From: Larry S.	Read Replies (1) \| Respond to of 53068

MRK is a basket case. There are two huge factors against it, beside the loss of revenue/income from Viox. 1. MRK is a huge institutional holding. There is massive bailing going on. Its too early for the "deep value" players to step up to the plate. I think MRK will become a teenager before the end of the year when tax loss selling really kicks in and final portfolio adjusting for end of year reports. 2. There is an unquantifiable liability for MRK due to potential deaths from a drug that was so widely used. the lawyers will or are going crazy over this one. tobacco, asbestos, and now Viox. A sign of things to come in the medical liability field? I have no position in MRK. Falling knives are falling knives. this puppy has a long ways to go to build a base. larry